Clinical Trial Update: Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin

View source ↗

Summary

Clinical trial update reporting health outcomes for patients with Type 2 Diabetes Mellitus treated with dapagliflozin in combination with insulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED